Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Psychiatry
Volume 2013 (2013), Article ID 761567, 3 pages
http://dx.doi.org/10.1155/2013/761567
Case Report

Venlafaxine-Induced Orthostatic Hypotension in a Geriatric Patient

1Department of Psychiatry, College of Medicine, University of Kentucky, Lexington, KY 40509, USA
2University of Kentucky Mental Health Research Center, Eastern State Hospital, Lexington, KY 40508, USA

Received 6 June 2013; Accepted 18 July 2013

Academic Editors: I. G. Anghelescu, M. Kellner, and J. Saiz-Ruiz

Copyright © 2013 Vidyashree Chikkaramanjegowda and Jose de Leon. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Consensus Committee of the American Autonomic Society and the American Academy of Neurology, “Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy,” Neurology, vol. 46, no. 5, p. 1470, 1996. View at Google Scholar · View at Scopus
  2. R. Freeman, W. Wieling, F. B. Axelrod et al., “Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome,” Clinical Autonomic Research, vol. 21, no. 2, pp. 69–72, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. E. Richelson, “Interactions of antidepressants with neurotransmitter transporters and receptors and their clinical relevance,” Journal of Clinical Psychiatry, vol. 64, no. 13, pp. 5–12, 2003. View at Google Scholar · View at Scopus
  4. J. P. Feighner, “Cardiovascular safety in depressed patients: focus on venlafaxine,” Journal of Clinical Psychiatry, vol. 56, no. 12, pp. 574–579, 1995. View at Google Scholar · View at Scopus
  5. M. E. Thase, “Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients,” Journal of Clinical Psychiatry, vol. 59, no. 10, pp. 502–508, 1998. View at Google Scholar · View at Scopus
  6. C. A. Naranjo, U. Busto, and E. M. Sellers, “A method for estimating the probability of adverse drug reactions,” Clinical Pharmacology and Therapeutics, vol. 30, no. 2, pp. 239–245, 1981. View at Google Scholar · View at Scopus
  7. H. S. Duggal, K. Jagadheesan, and H. S. Nizamie, “Venlafaxine—induced orthostatic hypotension,” Indian Journal of Psychiatry, vol. 43, pp. 371–373, 2001. View at Google Scholar
  8. E. M. Johnson, E. Whyte, B. H. Mulsant et al., “Cardiovascular changes associated with venlafaxine in the treatment of late-life depression,” American Journal of Geriatric Psychiatry, vol. 14, no. 9, pp. 796–802, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. C. P. Alderman and M. D. Wiese, “Unexpected orthostatic hypotension with venlafaxine,” Australian Journal of Hospital Pharmacy, vol. 29, no. 4, pp. 215–216, 1999. View at Google Scholar · View at Scopus
  10. J. E. Mazur, J. D. Doty, and A. S. Krygiel, “Fatality related to a 30-g venlafaxine overdose,” Pharmacotherapy, vol. 23, no. 12, pp. 1668–1672, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Shi and U. Klotz, “Age-related changes in pharmacokinetics,” Current Drug Metabolism, vol. 12, no. 7, pp. 601–610, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Trifiró and E. Spina, “Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems,” Current Drug Metabolism, vol. 12, no. 7, pp. 611–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Unterecker, C. Hiemke, C. Greiner et al., “The effect of age, sex, smoking and co-medication on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions,” Pharmacopsychiatry, vol. 45, pp. 229–235, 2012. View at Google Scholar